Showing results (2931-2940 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|November 22, 2021
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational studySatoshi Igawa, Tomoya Fukui, Masashi Kasajima, et al.
Investigational New Drugs|January 15, 2022
Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trialDaobin Zhou, Wei Xu, Hongbing Ma, et al.
Investigational New Drugs|January 17, 2022
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencingGabriel Roman Souza, Ahmed Abdalla, Sukeshi Arora, et al.
Investigational New Drugs|November 24, 2021
Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma modelHideki Kashiwagi, Shinji Kawabata, Kohei Yoshimura, et al.
Investigational New Drugs|August 30, 2022
BMP2 as a promising anticancer approach: functions and molecular mechanismsTong-Tong Li, Yong-Wei Lai, Xu Han, et al.
Investigational New Drugs|August 31, 2022
Combination of ruxolitinib with ABT-737 exhibits synergistic effects in cells carrying concurrent JAK2V617F and ASXL1 mutationsJiajia Yuan, Junzhe Song, Chao Chen, et al.
Investigational New Drugs|March 11, 2021
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patientsJulian Taugner, Lukas Käsmann, Chukwuka Eze, et al.
Investigational New Drugs|September 8, 2022
CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphomaBo Xu, Shaoqian Li, Bo Kang, et al.
Investigational New Drugs|January 1, 1986
Cytotoxicity of combinations of prostaglandin D2 (PGD2) and antitumor drugs for B16 melanoma cells in cultureB K Bhuyan, G J Badiner, E G Adams, et al.
Investigational New Drugs|November 3, 2021
Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world dataXiaowei Zhang, Feng Jin, Shiyu Jiang, et al.
Pageof 372